{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:17:01Z","timestamp":1784269021714,"version":"3.55.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province of China","doi-asserted-by":"crossref","award":["2023JJ40982"],"award-info":[{"award-number":["2023JJ40982"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Project of the Health Commission of Hunan Province","award":["202203024375"],"award-info":[{"award-number":["202203024375"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11151-2","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T19:28:38Z","timestamp":1753298918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular function validation and prognostic value analysis of the cuproptosis-related gene ferredoxin 1 in papillary thyroid carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Shiyue","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"11151_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cac2.12197","volume":"41","author":"H Qiu","year":"2021","unstructured":"Qiu, H., Cao, S. & Xu, R. Cancer incidence, mortality, and burden in china: a time-trend analysis and comparison with the united States and united Kingdom based on the global epidemiological data released in 2020. Cancer Commun.. 41, 1037\u20131048 (2021).","journal-title":"Cancer Commun."},{"key":"11151_CR2","doi-asserted-by":"crossref","unstructured":"Huang, J. et al. Incidence and mortality of thyroid cancer in 50 countries: A joinpoint regression analysis of global trends. Endocrine (2023).","DOI":"10.1007\/s12020-022-03274-7"},{"key":"11151_CR3","doi-asserted-by":"crossref","unstructured":"Yan, K. L. et al. Rising incidence and incidence-Based mortality of thyroid Cancer in california, 2000\u20132017. J Clin. Endocrinol. Metab 105. (2020).","DOI":"10.1210\/clinem\/dgaa121"},{"key":"11151_CR4","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1097\/RLU.0000000000002078","volume":"43","author":"K Nakanishi","year":"2018","unstructured":"Nakanishi, K. et al. Impact of patient age and histological type on radioactive iodine avidity of recurrent lesions of differentiated thyroid carcinoma. Clin. Nucl. Med. 43, 482\u2013485 (2018).","journal-title":"Clin. Nucl. Med."},{"key":"11151_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12967-022-03848-z","volume":"21","author":"D Chen","year":"2023","unstructured":"Chen, D. et al. Papillary thyroid cancer organoids harboring BRAF(V600E) mutation reveal potentially beneficial effects of BRAF inhibitor-based combination therapies. J. Transl Med. 21, 9 (2023).","journal-title":"J. Transl Med."},{"key":"11151_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. Cell. Death Differ. 25, 486\u2013541 (2018).","journal-title":"Cell. Death Differ."},{"key":"11151_CR7","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41392-022-01110-y","volume":"7","author":"F Peng","year":"2022","unstructured":"Peng, F. et al. Regulated cell death (RCD) in cancer: key pathways and targeted therapies. Signal. Transduct. Target. Ther. 7, 286 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"11151_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1158\/2159-8290.CD-20-0789","volume":"11","author":"E Koren","year":"2021","unstructured":"Koren, E. & Fuchs, Y. Modes of regulated cell death in Cancer. Cancer Discov. 11, 245\u2013265 (2021).","journal-title":"Cancer Discov"},{"key":"11151_CR9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","volume":"7","author":"W Gao","year":"2022","unstructured":"Gao, W., Wang, X., Zhou, Y., Wang, X. & Yu, Y. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal. Transduct. Target. Ther. 7, 196 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"11151_CR10","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","volume":"15","author":"X Tong","year":"2022","unstructured":"Tong, X. et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and Cuproptosis research. J. Hematol. Oncol. 15, 174 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"11151_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen, L., Min, J. & Wang, F. Copper homeostasis and Cuproptosis in health and disease. Signal. Transduct. Target. Ther. 7, 378 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"11151_CR12","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P. et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375, 1254\u20131261 (2022).","journal-title":"Science"},{"key":"11151_CR13","doi-asserted-by":"crossref","unstructured":"Ma, S. et al. A Pan-Cancer analysis of prognosis and immunity of cuproptosis-related gene FDX1. Res. Square (2022).","DOI":"10.21203\/rs.3.rs-1632036\/v1"},{"key":"11151_CR14","unstructured":"People NHCot, #39, A. & sRoCM, Administration, H. \u7532\u72b6\u817a\u764c\u8bca\u7597\u6307\u5357(2022\u5e74\u7248) %J \u4e2d\u56fd\u5b9e\u7528\u5916\u79d1\u6742\u5fd7. 42, 1343\u20131357 (2022)."},{"key":"11151_CR15","doi-asserted-by":"publisher","first-page":"e276","DOI":"10.1097\/SLA.0000000000003632","volume":"274","author":"J Limberg","year":"2021","unstructured":"Limberg, J. et al. Does aggressive variant histology without invasive features predict overall survival in papillary thyroid cancer?? A National cancer? database analysis. Ann. Surg. 274, e276\u2013e281 (2021).","journal-title":"Ann. Surg."},{"key":"11151_CR16","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1089\/thy.2021.0267","volume":"31","author":"A Sato","year":"2021","unstructured":"Sato, A. et al. Circulating tumor DNA harboring the BRAF(V600E) mutation May predict poor outcomes of primary papillary thyroid Cancer patients. Thyroid 31, 1822\u20131828 (2021).","journal-title":"Thyroid"},{"key":"11151_CR17","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1038\/s41467-020-18497-3","volume":"11","author":"J Yu","year":"2020","unstructured":"Yu, J. et al. Lymph node metastasis prediction of papillary thyroid carcinoma based on transfer learning radiomics. Nat. Commun. 11, 4807 (2020).","journal-title":"Nat. Commun."},{"key":"11151_CR18","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41419-020-03294-z","volume":"12","author":"Z Yang","year":"2021","unstructured":"Yang, Z. et al. A new risk factor indicator for papillary thyroid cancer based on immune infiltration. Cell. Death Dis. 12, 51 (2021).","journal-title":"Cell. Death Dis."},{"key":"11151_CR19","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.7150\/ijbs.72397","volume":"18","author":"X Zhu","year":"2022","unstructured":"Zhu, X. et al. DNMT3B-mediated FAM111B methylation promotes papillary thyroid tumor glycolysis, growth and metastasis. Int. J. Biol. Sci. 18, 4372\u20134387 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"11151_CR20","doi-asserted-by":"publisher","first-page":"114830","DOI":"10.1016\/j.biopha.2023.114830","volume":"163","author":"D Wang","year":"2023","unstructured":"Wang, D. et al. The molecular mechanisms of Cuproptosis and its relevance to cardiovascular disease. Biomed. Pharmacother. 163, 114830 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"11151_CR21","doi-asserted-by":"publisher","first-page":"115522","DOI":"10.1016\/j.biopha.2023.115522","volume":"167","author":"G Lei","year":"2023","unstructured":"Lei, G. et al. The potential of targeting Cuproptosis in the treatment of kidney renal clear cell carcinoma. Biomed. Pharmacother. 167, 115522 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"11151_CR22","doi-asserted-by":"publisher","first-page":"1074271","DOI":"10.3389\/fimmu.2022.1074271","volume":"13","author":"Y Yuan","year":"2022","unstructured":"Yuan, Y., Fu, M., Li, N. & Ye, M. Identification of immune infiltration and cuproptosis-related subgroups in crohn\u2019s disease. Front. Immunol. 13, 1074271 (2022).","journal-title":"Front. Immunol."},{"key":"11151_CR23","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1007\/s10495-023-01845-1","volume":"28","author":"J Lu","year":"2023","unstructured":"Lu, J. et al. FDX1 enhances endometriosis cell Cuproptosis via G6PD-mediated redox homeostasis. Apoptosis 28, 1128\u20131140 (2023).","journal-title":"Apoptosis"},{"key":"11151_CR24","doi-asserted-by":"publisher","first-page":"1039510","DOI":"10.3389\/fimmu.2022.1039510","volume":"13","author":"G Li","year":"2022","unstructured":"Li, G. et al. Appropriate level of Cuproptosis May be involved in alleviating pulmonary fibrosis. Front. Immunol. 13, 1039510 (2022).","journal-title":"Front. Immunol."},{"key":"11151_CR25","doi-asserted-by":"publisher","first-page":"114301","DOI":"10.1016\/j.biopha.2023.114301","volume":"159","author":"W Yang","year":"2023","unstructured":"Yang, W. et al. 4-Octyl Itaconate inhibits aerobic Glycolysis by targeting GAPDH to promote Cuproptosis in colorectal cancer. Biomed. Pharmacother. 159, 114301 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"11151_CR26","doi-asserted-by":"crossref","unstructured":"Lu, H. et al. A novel oncogenic role of FDX1 in human melanoma related to PD-L1 immune checkpoint. Int J. Mol. Sci 24. (2023).","DOI":"10.3390\/ijms24119182"},{"key":"11151_CR27","doi-asserted-by":"publisher","first-page":"919231","DOI":"10.3389\/fimmu.2022.919231","volume":"13","author":"M Yang","year":"2022","unstructured":"Yang, M. et al. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related LncRNA. Front. Immunol. 13, 919231 (2022).","journal-title":"Front. Immunol."},{"key":"11151_CR28","doi-asserted-by":"publisher","first-page":"1090596","DOI":"10.3389\/fimmu.2023.1090596","volume":"14","author":"B Chang","year":"2023","unstructured":"Chang, B., Hu, Z., Chen, L., Jin, Z. & Yang, Y. Development and validation of cuproptosis-related genes in synovitis during osteoarthritis progress. Front. Immunol. 14, 1090596 (2023).","journal-title":"Front. Immunol."},{"key":"11151_CR29","doi-asserted-by":"publisher","first-page":"1103509","DOI":"10.3389\/fimmu.2023.1103509","volume":"14","author":"Y Zhou","year":"2023","unstructured":"Zhou, Y. et al. Identification of copper death-associated molecular clusters and immunological profiles in rheumatoid arthritis. Front. Immunol. 14, 1103509 (2023).","journal-title":"Front. Immunol."},{"key":"11151_CR30","doi-asserted-by":"publisher","first-page":"1033859","DOI":"10.3389\/fphar.2023.1033859","volume":"14","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Cuproptosis-related genes signature and validation of differential expression and the potential targeting drugs in Temporal lobe epilepsy. Front. Pharmacol. 14, 1033859 (2023).","journal-title":"Front. Pharmacol."},{"key":"11151_CR31","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/0026-0495(82)90141-X","volume":"31","author":"H Lithell","year":"1982","unstructured":"Lithell, H., Jacobs, I., Vessby, B., Hellsing, K. & Karlsson, J. Decrease of lipoprotein lipase activity in skeletal muscle in man during a short-term carbohydrate-rich dietary regime. With special reference to HDL-cholesterol, Apolipoprotein and insulin concentrations. Metabolism 31, 994\u2013998 (1982).","journal-title":"Metabolism"},{"key":"11151_CR32","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun, L. et al. Lactylation of METTL16 promotes Cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat. Commun. 14, 6523 (2023).","journal-title":"Nat. Commun."},{"key":"11151_CR33","doi-asserted-by":"publisher","first-page":"e14380","DOI":"10.1111\/cns.14380","volume":"30","author":"S Feng","year":"2024","unstructured":"Feng, S. et al. Cuproptosis facilitates immune activation but promotes immune escape, and a machine learning-based cuproptosis-related signature is identified for predicting prognosis and immunotherapy response of gliomas. CNS Neurosci. Ther. 30, e14380 (2024).","journal-title":"CNS Neurosci. Ther."},{"key":"11151_CR34","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.2217\/epi-2023-0230","volume":"15","author":"S Qian","year":"2023","unstructured":"Qian, S., Liu, J., Liao, W. & Wang, F. METTL3 promotes non-small-cell lung cancer growth and metastasis by inhibiting FDX1 through copper death-associated pri-miR-21-5p maturation. Epigenomics 15, 1237\u20131255 (2023).","journal-title":"Epigenomics"},{"key":"11151_CR35","doi-asserted-by":"publisher","first-page":"981764","DOI":"10.3389\/fimmu.2022.981764","volume":"13","author":"J Xu","year":"2022","unstructured":"Xu, J. et al. Multi-omics pan-cancer study of Cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma. Front. Immunol. 13, 981764 (2022).","journal-title":"Front. Immunol."},{"key":"11151_CR36","doi-asserted-by":"publisher","first-page":"999823","DOI":"10.3389\/fimmu.2022.999823","volume":"13","author":"T Wang","year":"2022","unstructured":"Wang, T. et al. Cuproptosis-related gene FDX1 expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma. Front. Immunol. 13, 999823 (2022).","journal-title":"Front. Immunol."},{"key":"11151_CR37","doi-asserted-by":"publisher","first-page":"925618","DOI":"10.3389\/fimmu.2022.925618","volume":"13","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. Cuproptosis-Related risk score predicts prognosis and characterizes the tumor microenvironment in hepatocellular carcinoma. Front. Immunol. 13, 925618 (2022).","journal-title":"Front. Immunol."},{"key":"11151_CR38","doi-asserted-by":"publisher","first-page":"1056932","DOI":"10.3389\/fimmu.2022.1056932","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Front. Immunol. 13, 1056932 (2022).","journal-title":"Front. Immunol."},{"key":"11151_CR39","doi-asserted-by":"publisher","first-page":"939776","DOI":"10.3389\/fmed.2022.939776","volume":"9","author":"H Lu","year":"2022","unstructured":"Lu, H. et al. Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma. Front. Med. (Lausanne). 9, 939776 (2022).","journal-title":"Front. Med. (Lausanne)"},{"key":"11151_CR40","doi-asserted-by":"crossref","unstructured":"Tim\u00f3n-G\u00f3mez, A., Bartley-Dier, E. L., Fontanesi, F. & Barrientos, A. HIGD-Driven regulation of cytochrome c oxidase biogenesis and function. Cells 9. (2020).","DOI":"10.3390\/cells9122620"},{"key":"11151_CR41","doi-asserted-by":"publisher","first-page":"23769","DOI":"10.1074\/jbc.M116.734665","volume":"291","author":"K R\u00f6mpler","year":"2016","unstructured":"R\u00f6mpler, K. et al. Overlapping role of respiratory supercomplex factor Rcf2 and its N-terminal homolog Rcf3 in Saccharomyces cerevisiae. J. Biol. Chem. 291, 23769\u201323778 (2016).","journal-title":"J. Biol. Chem."},{"key":"11151_CR42","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1038\/s41388-022-02226-9","volume":"41","author":"B Chen","year":"2022","unstructured":"Chen, B. et al. DNA damage-induced translocation of mitochondrial factor HIGD1A into the nucleus regulates homologous recombination and radio\/chemo-sensitivity. Oncogene 41, 1918\u20131930 (2022).","journal-title":"Oncogene"},{"key":"11151_CR43","doi-asserted-by":"crossref","unstructured":"Lv, J. L. et al. Procyanidin C1 inhibits tumor growth and metastasis in colon cancer via modulating miR-501-3p\/HIGD1A axis. J. Adv. Res (2023).","DOI":"10.1016\/j.jare.2023.07.007"},{"key":"11151_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.canlet.2019.07.007","volume":"461","author":"HJ An","year":"2019","unstructured":"An, H. J. et al. Higd-1a regulates the proliferation of pancreatic cancer cells through a pERK\/p27(KIP1)\/pRB pathway. Cancer Lett. 461, 78\u201389 (2019).","journal-title":"Cancer Lett."},{"key":"11151_CR45","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41419-020-02823-0","volume":"11","author":"Z Cheng","year":"2020","unstructured":"Cheng, Z., Wang, G., Zhu, W., Luo, C. & Guo, Z. LEF1-AS1 accelerates tumorigenesis in glioma by sponging miR-489-3p to enhance HIGD1A. Cell. Death Dis. 11, 690 (2020).","journal-title":"Cell. Death Dis."},{"key":"11151_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40170-024-00334-6","volume":"12","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Elevated expression of HIGD1A drives hepatocellular carcinoma progression by regulating polyamine metabolism through c-Myc-ODC1 nexus. Cancer Metab. 12, 7 (2024).","journal-title":"Cancer Metab."},{"key":"11151_CR47","doi-asserted-by":"crossref","unstructured":"Jiang, A. et al. SPCS, a novel classifier system based on senescence Axis regulators reveals tumor microenvironment heterogeneity and guides frontline therapy for clear cell renal carcinoma. Clin. Genitourin. Cancer (2024).","DOI":"10.1016\/j.clgc.2024.01.005"},{"key":"11151_CR48","first-page":"860","volume":"55","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. Genome\u2013wide investigation of the clinical implications and molecular mechanism of long noncoding RNA LINC00668 and protein\u2013coding genes in hepatocellular carcinoma. Int. J. Oncol. 55, 860\u2013878 (2019).","journal-title":"Int. J. Oncol."},{"key":"11151_CR49","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000134199","volume":"72","author":"K Ozaki","year":"1996","unstructured":"Ozaki, K. et al. Cloning, expression and chromosomal mapping of a novel cyclophilin-related gene (PPIL1) from human fetal brain. Cytogenet. Cell. Genet. 72, 242\u2013245 (1996).","journal-title":"Cytogenet. Cell. Genet."},{"key":"11151_CR50","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nature01116","volume":"419","author":"H Zheng","year":"2002","unstructured":"Zheng, H. et al. The Prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 419, 849\u2013853 (2002).","journal-title":"Nature"},{"key":"11151_CR51","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1158\/1078-0432.CCR-05-0588","volume":"12","author":"K Obama","year":"2006","unstructured":"Obama, K. et al. Overexpression of peptidyl-prolyl isomerase-like 1 is associated with the growth of colon cancer cells. Clin. Cancer Res. 12, 70\u201376 (2006).","journal-title":"Clin. Cancer Res."},{"key":"11151_CR52","doi-asserted-by":"publisher","first-page":"111742","DOI":"10.1016\/j.celrep.2022.111742","volume":"41","author":"AH Janneh","year":"2022","unstructured":"Janneh, A. H. et al. Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis. Cell. Rep. 41, 111742 (2022).","journal-title":"Cell. Rep."},{"key":"11151_CR53","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00424-013-1401-2","volume":"466","author":"O Andrini","year":"2014","unstructured":"Andrini, O. et al. CLCNKB mutations causing mild Bartter syndrome profoundly alter the pH and Ca2\u2009+\u2009dependence of ClC-Kb channels. Pflugers Arch. 466, 1713\u20131723 (2014).","journal-title":"Pflugers Arch."},{"key":"11151_CR54","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1158\/0008-5472.CAN-12-0656","volume":"72","author":"AH Girgis","year":"2012","unstructured":"Girgis, A. H. et al. Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma. Cancer Res. 72, 5273\u20135284 (2012).","journal-title":"Cancer Res."},{"key":"11151_CR55","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1038\/s41598-022-11760-1","volume":"12","author":"J Dai","year":"2022","unstructured":"Dai, J. et al. Establishment of prognostic risk model and drug sensitivity based on prognostic related genes of esophageal cancer. Sci. Rep. 12, 8008 (2022).","journal-title":"Sci. Rep."},{"key":"11151_CR56","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1083\/jcb.201708064","volume":"217","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Src-mediated phosphorylation converts FHL1 from tumor suppressor to tumor promoter. J. Cell. Biol. 217, 1335\u20131351 (2018).","journal-title":"J. Cell. Biol."},{"key":"11151_CR57","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s13402-023-00793-x","volume":"46","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q. et al. VE-822 upregulates the deubiquitinase OTUD1 to stabilize FHL1 to inhibit the progression of lung adenocarcinoma. Cell. Oncol. (Dordr). 46, 1001\u20131014 (2023).","journal-title":"Cell. Oncol. (Dordr)"},{"key":"11151_CR58","doi-asserted-by":"crossref","unstructured":"Chen, J. et al. Overexpression of FHL1 suppresses papillary thyroid cancer proliferation and progression via inhibiting Wnt\/\u03b2-catenin pathway. Endocrine (2024).","DOI":"10.1007\/s12020-023-03675-2"},{"key":"11151_CR59","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/ncb1757","volume":"10","author":"H Nojima","year":"2008","unstructured":"Nojima, H. et al. IQGAP3 regulates cell proliferation through the ras\/erk signalling cascade. Nat. Cell. Biol. 10, 971\u2013978 (2008).","journal-title":"Nat. Cell. Biol."},{"key":"11151_CR60","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1242\/jcs.03356","volume":"120","author":"S Wang","year":"2007","unstructured":"Wang, S. et al. IQGAP3, a novel effector of Rac1 and Cdc42, regulates neurite outgrowth. J. Cell. Sci. 120, 567\u2013577 (2007).","journal-title":"J. Cell. Sci."},{"key":"11151_CR61","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1158\/1541-7786.MCR-20-0639","volume":"19","author":"M Leone","year":"2021","unstructured":"Leone, M. et al. IQGAP3, a YAP target, is required for proper Cell-Cycle progression and genome stability. Mol. Cancer Res. 19, 1712\u20131726 (2021).","journal-title":"Mol. Cancer Res."},{"key":"11151_CR62","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12935-019-0881-3","volume":"19","author":"H Cao","year":"2019","unstructured":"Cao, H. et al. Clinical value of detecting IQGAP3, B7-H4 and cyclooxygenase-2 in the diagnosis and prognostic evaluation of colorectal cancer. Cancer Cell. Int. 19, 163 (2019).","journal-title":"Cancer Cell. Int."},{"key":"11151_CR63","doi-asserted-by":"publisher","first-page":"584450","DOI":"10.3389\/fphar.2020.584450","volume":"11","author":"X Hua","year":"2020","unstructured":"Hua, X. et al. IQGAP3 overexpression correlates with poor prognosis and radiation therapy resistance in breast Cancer. Front. Pharmacol. 11, 584450 (2020).","journal-title":"Front. Pharmacol."},{"key":"11151_CR64","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.canlet.2020.08.042","volume":"493","author":"Y Zeng","year":"2020","unstructured":"Zeng, Y. et al. IQGAP3 interacts with Rad17 to recruit the Mre11-Rad50-Nbs1 complex and contributes to radioresistance in lung cancer. Cancer Lett. 493, 254\u2013265 (2020).","journal-title":"Cancer Lett."},{"key":"11151_CR65","doi-asserted-by":"publisher","first-page":"606327","DOI":"10.3389\/fcell.2020.606327","volume":"8","author":"M Wu","year":"2020","unstructured":"Wu, M. et al. Progression risk assessment of Post-surgical papillary thyroid carcinoma based on circular RNA-Associated competing endogenous RNA mechanisms. Front. Cell. Dev. Biol. 8, 606327 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"key":"11151_CR66","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0092-8674(00)80085-9","volume":"86","author":"X Liu","year":"1996","unstructured":"Liu, X., Kim, C. N., Yang, J., Jemmerson, R. & Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147\u2013157 (1996).","journal-title":"Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11151-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11151-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11151-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T21:16:38Z","timestamp":1757279798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11151-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11151"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11151-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Joint Ethics Committee of the Central South University Health Authority.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"26845"}}